On-Demand Webinars

1. HPAPI Drug Product Development And Manufacturing Using Micronization Technology

   Learn how to classify HPAPIs in early development and recommendations for safe product handling, from clinical manufacturing to commercialization.

2. Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

   Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

3. Navigating Primary Packaging Challenges, Solutions For Emerging Innovators 12/5/2024

   If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

4. Novel Applications In Pharmaceutical Spray Drying 3/10/2025

   Whether working with small-scale formulations or preparing for commercial manufacturing, this session will provide actionable strategies to optimize development pipelines.

5. Dry Powder Inhalable Vaccines For Shelf Stability And Global Access 6/3/2024

   What if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines and manufacturing considerations for dry powder inhaled vaccines.

6. Nanoparticle Enabled Formulation And Drug Delivery Solutions

   Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

7. Selecting Containers For Sensitive And Costly Cell & Gene Therapies

   Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.

8. OSD Manufacturing For Pediatrics And Other Special Patient Populations 8/29/2024

   Watch to hear Steven Facer, Adare's Vice President of Business Development EU/ROW, discuss the challenges of pediatric oral solid dose manufacturing and how to overcome them.

9. Regulatory, Cost Implications Of Switching Injectable Delivery Formats

   Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit. 

10. Identify And Mitigate Absorption Risks With PBPK Modeling 3/12/2024

    See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.